PortfoliosLab logo
MED vs. VFC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MED and VFC is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MED vs. VFC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and V.F. Corporation (VFC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MED:

-0.93

VFC:

0.03

Sortino Ratio

MED:

-1.52

VFC:

0.51

Omega Ratio

MED:

0.83

VFC:

1.07

Calmar Ratio

MED:

-0.47

VFC:

-0.02

Martin Ratio

MED:

-1.28

VFC:

-0.07

Ulcer Index

MED:

35.24%

VFC:

23.95%

Daily Std Dev

MED:

44.81%

VFC:

73.14%

Max Drawdown

MED:

-98.33%

VFC:

-88.41%

Current Drawdown

MED:

-95.44%

VFC:

-85.71%

Fundamentals

Market Cap

MED:

$147.39M

VFC:

$4.74B

EPS

MED:

-$0.64

VFC:

-$0.37

PEG Ratio

MED:

1.95

VFC:

0.14

PS Ratio

MED:

0.27

VFC:

0.50

PB Ratio

MED:

0.70

VFC:

2.82

Total Revenue (TTM)

MED:

$543.45M

VFC:

$7.50B

Gross Profit (TTM)

MED:

$401.58M

VFC:

$4.04B

EBITDA (TTM)

MED:

$6.40M

VFC:

$466.30M

Returns By Period

In the year-to-date period, MED achieves a -23.89% return, which is significantly higher than VFC's -43.82% return. Over the past 10 years, MED has outperformed VFC with an annualized return of -5.87%, while VFC has yielded a comparatively lower -13.11% annualized return.


MED

YTD

-23.89%

1M

10.64%

6M

-27.16%

1Y

-41.08%

3Y*

-54.65%

5Y*

-29.84%

10Y*

-5.87%

VFC

YTD

-43.82%

1M

8.01%

6M

-38.66%

1Y

2.35%

3Y*

-33.36%

5Y*

-23.88%

10Y*

-13.11%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Medifast, Inc.

V.F. Corporation

Risk-Adjusted Performance

MED vs. VFC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
The Risk-Adjusted Performance Rank of MED is 1111
Overall Rank
The Sharpe Ratio Rank of MED is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 66
Sortino Ratio Rank
The Omega Ratio Rank of MED is 99
Omega Ratio Rank
The Calmar Ratio Rank of MED is 2121
Calmar Ratio Rank
The Martin Ratio Rank of MED is 1515
Martin Ratio Rank

VFC
The Risk-Adjusted Performance Rank of VFC is 5252
Overall Rank
The Sharpe Ratio Rank of VFC is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of VFC is 5252
Sortino Ratio Rank
The Omega Ratio Rank of VFC is 5555
Omega Ratio Rank
The Calmar Ratio Rank of VFC is 5050
Calmar Ratio Rank
The Martin Ratio Rank of VFC is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MED vs. VFC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and V.F. Corporation (VFC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MED Sharpe Ratio is -0.93, which is lower than the VFC Sharpe Ratio of 0.03. The chart below compares the historical Sharpe Ratios of MED and VFC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

MED vs. VFC - Dividend Comparison

MED has not paid dividends to shareholders, while VFC's dividend yield for the trailing twelve months is around 3.00%.


TTM20242023202220212020201920182017201620152014
MED
Medifast, Inc.
0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%0.00%
VFC
V.F. Corporation
3.00%1.68%5.27%7.28%2.69%2.26%1.91%2.65%2.33%2.87%2.14%1.48%

Drawdowns

MED vs. VFC - Drawdown Comparison

The maximum MED drawdown since its inception was -98.33%, which is greater than VFC's maximum drawdown of -88.41%. Use the drawdown chart below to compare losses from any high point for MED and VFC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MED vs. VFC - Volatility Comparison

The current volatility for Medifast, Inc. (MED) is 11.51%, while V.F. Corporation (VFC) has a volatility of 22.71%. This indicates that MED experiences smaller price fluctuations and is considered to be less risky than VFC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MED vs. VFC - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and V.F. Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20212022202320242025
115.73M
2.83B
(MED) Total Revenue
(VFC) Total Revenue
Values in USD except per share items

MED vs. VFC - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and V.F. Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20212022202320242025
72.8%
56.3%
(MED) Gross Margin
(VFC) Gross Margin
MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported a gross profit of 84.25M and revenue of 115.73M. Therefore, the gross margin over that period was 72.8%.

VFC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, V.F. Corporation reported a gross profit of 1.60B and revenue of 2.83B. Therefore, the gross margin over that period was 56.3%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported an operating income of -1.26M and revenue of 115.73M, resulting in an operating margin of -1.1%.

VFC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, V.F. Corporation reported an operating income of 225.78M and revenue of 2.83B, resulting in an operating margin of 8.0%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported a net income of -772.00K and revenue of 115.73M, resulting in a net margin of -0.7%.

VFC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, V.F. Corporation reported a net income of 167.78M and revenue of 2.83B, resulting in a net margin of 5.9%.